Robert Lechleider

Robert Lechleider appears in our data through filings on Immunome Inc. shares, published by SEC (Form 4). The record holds 9 filings, for trades running from 21 November 2024 to 23 July 2026.

The open-market side counts 1 purchase for €142k alongside 5 sales for €1.1M. No amount is published for 2 filings, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 1 share grant and 2 option exercises. So far in 2026, the count stands at no purchases and 5 sales.

The latest filing, published on 27 July 2026, reports a share grant in Immunome Inc. The last purchase on record was published on 25 November 2024, which is 692 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.